اعلان شركة جنى الطبية عن استقالة وتعيين الرئيس التنفيذي

Jana Medical Co. Announces Resignation and Appointment of a CEO 9616 JANA 0.00 % 1447/06/02     23/11/2025 07:51:46 Introduction Jana Medical Company announces the resignation of Mr. Rassam bin Sultan Al-Otaibi from his position as Acting CEO, effective November 23, 2025. He will remain a member of the Board of Directors. The Board of Directors has approved the appointment of Mr. Ziyad bin Saleh Al-Sulais as CEO of Jana Medical Company, effective November 23, 2025. Name of the Resigned Person Rassam bin Sultan Al-Otaibi Resignation Acceptance Date 2025-11-22 Corresponding to 1447-06-01 Resignation Effective Date 2025-11-23 Corresponding to 1447-06-02 Reasons for Resignation At his request Appointment Type Appointment Name of the Appointed Person Ziyad bin Saleh Al-Sulais Date of Board Resolution 2025-11-22 Corresponding to 1447-06-01 Date Work Commencement 2025-11-23 Corresponding to 1447-06-02 Brief Resume Mr. Ziad holds a Bachelor's degree in Administrative Development and Organization from King Abdulaziz University, and an Executive MBA from HEC Paris specializing in Corporate Governance and Board Management. He has also completed several executive studies at prestigious international universities, including London Business School, IMD Business School in Switzerland, Babson College in San Francisco, Cranfield University in the UK, and New York University in the USA. Mr. Ziad possesses over 20 years of experience in international companies, the private sector, and the public sector. He has worked for leading companies in the healthcare sector, holding numerous executive management positions and serving on boards of directors and national committees. This appointment aims to support the company's growth strategy. The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. Share